An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
An observational cohort study on pulmonary function in adult patients with 5q-spinal muscular atrophy under nusinersen therapy ; volume:270 ; number:7 ; day:16 ; month:4 ; year:2023 ; pages:3616-3622 ; date:7.2023
Journal of neurology ; 270, Heft 7 (16.4.2023), 3616-3622, 7.2023
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-023-11711-4
- URN
-
urn:nbn:de:101:1-2023092012360278412976
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bjelica, Bogdan
- Wohnrade, Camilla
- Osmanovic, Alma
- Schreiber-Katz, Olivia
- Petri, Susanne
- SpringerLink (Online service)
Other Objects (12)
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review
Nusinersen: A Review in 5q Spinal Muscular Atrophy
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy
Correction to: Nusinersen: A Review in 5q Spinal Muscular Atrophy
Experiences from treating seven adult 5q spinal muscular atrophy patients with Nusinersen
Therapeutic advances in 5q-linked spinal muscular atrophy
Pattern of pareses in 5q-spinal muscular atrophy
Managing intrathecal administration of nusinersen in adolescents and adults with 5q-spinal muscular atrophy and previous spinal surgery
Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients
Biomarkers in 5q-associated spinal muscular atrophy—a narrative review
Nusinersen effectiveness and safety in pediatric patients with 5q-spinal muscular atrophy: a multi-center disease registry in China
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy